Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC P-18:0/22:6 or PC O-18:1/22:6)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004217 AN007016 Lipid Alterations in ASAH1-Deficient Cells: Insights into Ceramide Accumulation and Lysosomal Dysfunction Cultured cells Human Metabolic disease Harvard Medical School LC-MS
ST003103 AN005077 Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach Blood Human COVID-19 Universidad CEU San Pablo GC-MS/LC-MS
ST001919 AN003118 Exposure to environmental contaminants is associated with alterations in hepatic lipid metabolism in non-alcoholic fatty liver disease Liver Mouse Fatty liver disease Örebro University LC-MS
ST001789 AN002901 Acute metabolomic changes of plasma in response to endurance exercise Blood Human University of California, San Diego LC-MS
ST001420 AN002375 Metabolomic analysis of patients with recurrent angina Blood Human Angina University of California, San Diego
ST000903 AN001470 Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament Blood Rat Stress Beijing Wonner Biotech. Ltd. Co. LC-MS
ST000617 AN000947 Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, San Diego LC-MS
ST000465 AN000727 Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response Kidney Human Cancer University of California, San Diego LC-MS
ST000450 AN000705 Metabolic features of chronic fatigue syndrome Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, San Diego LC-MS
  logo